"rho GTP-Binding Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A large family of MONOMERIC GTP-BINDING PROTEINS that are involved in regulation of actin organization, gene expression and cell cycle progression. This enzyme was formerly listed as EC 3.6.1.47.
Descriptor ID |
D020741
|
MeSH Number(s) |
D08.811.277.040.330.300.400.700 D12.644.360.525.700 D12.776.157.325.515.700 D12.776.476.525.700
|
Concept/Terms |
rho GTP-Binding Proteins- rho GTP-Binding Proteins
- GTP-Binding Proteins, rho
- rho GTP Binding Proteins
- P21 (rho)Protein
- rho GTP-Binding Protein
- GTP-Binding Protein, rho
- rho GTP Binding Protein
- rho GTPases
- GTPases, rho
- rho Small GTP-Binding Proteins
- rho Small GTP Binding Proteins
- rho Protein P21
- P21, rho Protein
- rho G-Proteins
- G-Proteins, rho
- rho G Proteins
|
Below are MeSH descriptors whose meaning is more general than "rho GTP-Binding Proteins".
Below are MeSH descriptors whose meaning is more specific than "rho GTP-Binding Proteins".
This graph shows the total number of publications written about "rho GTP-Binding Proteins" by people in this website by year, and whether "rho GTP-Binding Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1999 | 1 | 0 | 1 |
2000 | 3 | 0 | 3 |
2001 | 1 | 1 | 2 |
2002 | 3 | 1 | 4 |
2003 | 1 | 3 | 4 |
2004 | 3 | 0 | 3 |
2005 | 2 | 2 | 4 |
2006 | 1 | 0 | 1 |
2007 | 1 | 1 | 2 |
2008 | 2 | 2 | 4 |
2009 | 2 | 1 | 3 |
2010 | 2 | 0 | 2 |
2011 | 3 | 0 | 3 |
2013 | 1 | 0 | 1 |
2014 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "rho GTP-Binding Proteins" by people in Profiles.
-
Yeganeh B, Wiechec E, Ande SR, Sharma P, Moghadam AR, Post M, Freed DH, Hashemi M, Shojaei S, Zeki AA, Ghavami S. Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease. Pharmacol Ther. 2014 Jul; 143(1):87-110.
-
Kim S, Dangelmaier C, Bhavanasi D, Meng S, Wang H, Goldfinger LE, Kunapuli SP. RhoG protein regulates glycoprotein VI-Fc receptor ?-chain complex-mediated platelet activation and thrombus formation. J Biol Chem. 2013 Nov 22; 288(47):34230-8.
-
Wu C, Agrawal S, Vasanji A, Drazba J, Sarkaria S, Xie J, Welch CM, Liu M, Anand-Apte B, Horowitz A. Rab13-dependent trafficking of RhoA is required for directional migration and angiogenesis. J Biol Chem. 2011 Jul 01; 286(26):23511-20.
-
Katiyar P, Aplin AE. FOXD3 regulates migration properties and Rnd3 expression in melanoma cells. Mol Cancer Res. 2011 May; 9(5):545-52.
-
Polizio AH, Chinchilla P, Chen X, Kim S, Manning DR, Riobo NA. Heterotrimeric Gi proteins link Hedgehog signaling to activation of Rho small GTPases to promote fibroblast migration. J Biol Chem. 2011 Jun 3; 286(22):19589-96.
-
Chatterjee M, van Golen KL. Farnesyl transferase inhibitor treatment of breast cancer cells leads to altered RhoA and RhoC GTPase activity and induces a dormant phenotype. Int J Cancer. 2011 Jul 1; 129(1):61-9.
-
Lucey M, Unger H, van Golen KL. RhoC GTPase activation assay. J Vis Exp. 2010; (42).
-
Navenot JM, Fujii N, Peiper SC. Activation of Rho and Rho-associated kinase by GPR54 and KiSS1 metastasis suppressor gene product induces changes of cell morphology and contributes to apoptosis. Mol Pharmacol. 2009 Jun; 75(6):1300-6.
-
Bhattacharyya R, Banerjee J, Khalili K, Wedegaertner PB. Differences in Galpha12- and Galpha13-mediated plasma membrane recruitment of p115-RhoGEF. Cell Signal. 2009 Jun; 21(6):996-1006.
-
Klein RM, Aplin AE. Rnd3 regulation of the actin cytoskeleton promotes melanoma migration and invasive outgrowth in three dimensions. Cancer Res. 2009 Mar 15; 69(6):2224-33.